6,7,4′-Trihydroxyisoflavone suppressed the estrogen receptor negative breast cancer growth via regulating glycogen synthase kinase-3β/β-catenin signaling
The hepatic metabolites of daidzein has been demonstrated to be more potent in chronic diseases than daidzein. However, the investigation of their roles in estrogen receptor (ER)-negative breast cancer is limited. Here, the hepatic metabolite of daidzein 6,7,4′-trihydroxyisoflavone inhibited cell pr...
Main Authors: | Jing Chen, Jaehoo Lee, Cheng Bao, Jin Tae Kim, Hong Jin Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-09-01
|
Series: | Journal of Functional Foods |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1756464618303797 |
Similar Items
-
Wnt/Glycogen Synthase Kinase 3β/β-catenin Signaling Activation Mediated Sevoflurane Preconditioning-induced Cardioprotection
by: Jin-Dong Liu, et al.
Published: (2015-01-01) -
Altered Wnt Signaling Pathway in Cognitive Impairment Caused by Chronic Intermittent Hypoxia: Focus on Glycogen Synthase Kinase-3β and β-catenin
by: Yue-Ying Pan, et al.
Published: (2016-01-01) -
Glycogen Synthase Kinase 3β in Cancer Biology and Treatment
by: Takahiro Domoto, et al.
Published: (2020-06-01) -
GSK-3β and Vitamin D Receptor are Involved in β-Catenin and Snail Signaling in High Glucose-Induced Epithelial-Mesenchymal Transition of Mouse Podocytes
by: Jia Guo, et al.
Published: (2014-04-01) -
The GSK3 kinase inhibitor lithium produces unexpected hyperphosphorylation of β-catenin, a GSK3 substrate, in human glioblastoma cells
by: Ata ur Rahman Mohammed Abdul, et al.
Published: (2018-01-01)